IL1B and lung cancer: The levels of inflammatory factors such as IL-1β, IL-6, TNF-α, and CRP in the serum of the lung cancer mice increased, promoting the activation of inflammatory cells and stimulating the release of inflammatory mediators, leading to an increased risk of systemic inflammatory response.